We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+14.76%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.1B
AUM Growth
+$4.5M
Cap. Flow
-$179M
Cap. Flow %
-8.52%
Top 10 Hldgs %
51.83%
Holding
429
New
31
Increased
83
Reduced
267
Closed
35

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$70.4M
2
FUTU icon
Futu Holdings
FUTU
+$30.9M
3
AAPL icon
Apple
AAPL
+$18.5M
4
MSFT icon
Microsoft
MSFT
+$11.9M
5
AMAT icon
Applied Materials
AMAT
+$9.76M

Sector Composition

Rank Sector Weight
1 Technology 43.87%
2 Consumer Discretionary 23.94%
3 Communication Services 11.36%
4 Healthcare 5.11%
5 Financials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
201
Thermo Fisher Scientific
TMO
$211B
$647K 0.03%
1,596
-3,994
-71% -$1.67M
IONS icon
202
Ionis Pharmaceuticals
IONS
$9.35B
$638K 0.03%
16,160
-311
-2% -$10.2K
RVMD icon
203
Revolution Medicines
RVMD
$40.2B
$628K 0.03%
17,075
+1,802
+12% +$69.2K
CYTK icon
204
Cytokinetics
CYTK
$11B
$625K 0.03%
18,919
+5,136
+37% +$179K
COHR icon
205
Coherent
COHR
$55.2B
$624K 0.03%
+7,000
New +$504K
CRSP icon
206
CRISPR Therapeutics
CRSP
$4.58B
$621K 0.03%
12,764
-884
-6% -$34.2K
SYK icon
207
Stryker
SYK
$127B
$620K 0.03%
1,566
-126
-7% -$47.1K
PFE icon
208
Pfizer
PFE
$140B
$614K 0.03%
25,337
-695
-3% -$16.2K
PCVX icon
209
Vaxcyte
PCVX
$7.89B
$598K 0.03%
18,398
+6,079
+49% +$199K
SWTX
210
DELISTED
SpringWorks Therapeutics
SWTX
$596K 0.03%
12,693
+2,326
+22% +$103K
IT icon
211
Gartner
IT
$9.41B
$591K 0.03%
1,463
-132
-8% -$55.2K
STX icon
212
Seagate
STX
$193B
$590K 0.03%
4,088
-200
-5% -$20.7K
RL icon
213
Ralph Lauren
RL
$22.2B
$588K 0.03%
2,143
DHR icon
214
Danaher
DHR
$135B
$571K 0.03%
2,893
-411
-12% -$79.7K
AKRO
215
DELISTED
Akero Therapeutics
AKRO
$555K 0.03%
10,395
+3,471
+50% +$158K
MDT icon
216
Medtronic
MDT
$107B
$546K 0.03%
6,258
-260
-4% -$22K
TOL icon
217
Toll Brothers
TOL
$14B
$543K 0.03%
4,758
ADMA icon
218
ADMA Biologics
ADMA
$1.92B
$541K 0.03%
29,683
+8,811
+42% +$180K
KEYS icon
219
Keysight
KEYS
$54.5B
$539K 0.03%
3,291
-244
-7% -$37.2K
PTCT icon
220
PTC Therapeutics
PTCT
$6.37B
$532K 0.03%
10,898
+5,564
+104% +$264K
KRYS icon
221
Krystal Biotech
KRYS
$9.88B
$532K 0.03%
3,870
+1,612
+71% +$237K
VOO icon
222
Vanguard S&P 500 ETF
VOO
$968B
$531K 0.03%
935
-463
-33% -$243K
ALKS icon
223
Alkermes
ALKS
$8.82B
$515K 0.02%
18,003
+3,943
+28% +$117K
HPE icon
224
Hewlett Packard
HPE
$63.2B
$508K 0.02%
24,831
-1,313
-5% -$22K
CI icon
225
Cigna
CI
$76.6B
$504K 0.02%
1,524
-126
-8% -$40.6K

Similar funds

E Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, E Fund Management held 429 positions worth $2.1B, up 0.21% from $2.09B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

E Fund Management withdrew a net $179M in Q2 2025, closing 35 positions and reducing 267 holdings. Its most notable exit was KE Holdings, an estimated $70.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, E Fund Management opened a new position in Invesco DB Oil Fund worth $11M.

  • E Fund Management's largest Q2 2025 buy was Invesco DB Oil Fund: 835,473 shares worth $11M.
  • E Fund Management added most to abrdn Physical Gold Shares ETF in Q2 2025, an estimated $19.9M increase.
  • E Fund Management's biggest Q2 2025 reduction was Futu Holdings, cutting an estimated $30.9M.
  • E Fund Management fully exited KE Holdings in Q2 2025, selling an estimated $70.4M.
  • E Fund Management's ten largest holdings make up 52% of its $2.1B portfolio in Q2 2025.
  • E Fund Management opened 31 new positions and closed 35 in Q2 2025.
  • E Fund Management's portfolio value rose 0.21% quarter-over-quarter to $2.1B.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.